Fintech News

‹ Latest Events

KNBIF
OTC

Kane Biotech Inc.

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026 - KNBIF

Published October 7, 2026

$0.02
+0.00%
Event

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026 - KNBIF

Read full article on globenewswire.com →
About Kane Biotech Inc.

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company''s diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.

Stock Price
$0.02
Price Change
-0.00%
Exchange Mix — Recent KNBIF Events

NASDAQ

0%

NYSE

0%

AMEX

0%

OTC

100%